These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 39060201)

  • 1. Mathematical modelling of the 100-day target for vaccine availability after the detection of a novel pathogen: A case study in Indonesia.
    Bilgin GM; Munira SL; Lokuge K; Glass K
    Vaccine; 2024 Aug; 42(21):126163. PubMed ID: 39060201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the 100 days mission for vaccines on COVID-19: a mathematical modelling study.
    Barnsley G; Olivera Mesa D; Hogan AB; Winskill P; Torkelson AA; Walker DG; Ghani AC; Watson OJ
    Lancet Glob Health; 2024 Nov; 12(11):e1764-e1774. PubMed ID: 39424569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study.
    Moore S; Hill EM; Tildesley MJ; Dyson L; Keeling MJ
    Lancet Infect Dis; 2021 Jun; 21(6):793-802. PubMed ID: 33743847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave.
    Hupert N; Marín-Hernández D; Gao B; Águas R; Nixon DF
    Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35012976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of adjusting public health, travel, and social measures during the roll-out of COVID-19 vaccination: a modelling study.
    Leung K; Wu JT; Leung GM
    Lancet Public Health; 2021 Sep; 6(9):e674-e682. PubMed ID: 34388389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global pandemic preparedness: learning from the COVID-19 vaccine development and distribution.
    Agampodi S; Mogeni OD; Chandler R; Pansuriya M; Kim JH; Excler JL
    Expert Rev Vaccines; 2024; 23(1):761-772. PubMed ID: 39167221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of COVID-19 on vaccine confidence and uptake: A systematic literature review.
    Vojtek I; van Wouw M; Thomson A
    Hum Vaccin Immunother; 2024 Dec; 20(1):2384180. PubMed ID: 39106971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing COVID-19 vaccine allocation strategies in India: A mathematical modelling study.
    Foy BH; Wahl B; Mehta K; Shet A; Menon GI; Britto C
    Int J Infect Dis; 2021 Feb; 103():431-438. PubMed ID: 33388436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing vaccine acceptance in pregnancy during the COVID-19 pandemic: A multicenter study from West Bengal, India.
    Khan T; Das RS; Jana M; Bhattacharya SD; Halder S; Ray S; Satpathi P; Ghosh T; Mukherjee K; Choudhury SP
    Hum Vaccin Immunother; 2024 Dec; 20(1):2383030. PubMed ID: 39082142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of early detection and vaccination strategy in COVID-19 eradication program in Jakarta, Indonesia.
    Aldila D; Samiadji BM; Simorangkir GM; Khosnaw SHA; Shahzad M
    BMC Res Notes; 2021 Apr; 14(1):132. PubMed ID: 33845887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 Vaccine Effectiveness and Digital Pandemic Surveillance in Germany (eCOV Study): Web Application-Based Prospective Observational Cohort Study.
    Lang AL; Hohmuth N; Višković V; Konigorski S; Scholz S; Balzer F; Remschmidt C; Leistner R
    J Med Internet Res; 2024 Jun; 26():e47070. PubMed ID: 38833299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using syndromic measures of mortality to capture the dynamics of COVID-19 in Java, Indonesia, in the context of vaccination rollout.
    Djaafara BA; Whittaker C; Watson OJ; Verity R; Brazeau NF; Widyastuti ; Oktavia D; Adrian V; Salama N; Bhatia S; Nouvellet P; Sherrard-Smith E; Churcher TS; Surendra H; Lina RN; Ekawati LL; Lestari KD; Andrianto A; Thwaites G; Baird JK; Ghani AC; Elyazar IRF; Walker PGT
    BMC Med; 2021 Jun; 19(1):146. PubMed ID: 34144715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study.
    Jentsch PC; Anand M; Bauch CT
    Lancet Infect Dis; 2021 Aug; 21(8):1097-1106. PubMed ID: 33811817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
    Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
    Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.
    Zhang Y; Zeng G; Pan H; Li C; Hu Y; Chu K; Han W; Chen Z; Tang R; Yin W; Chen X; Hu Y; Liu X; Jiang C; Li J; Yang M; Song Y; Wang X; Gao Q; Zhu F
    Lancet Infect Dis; 2021 Feb; 21(2):181-192. PubMed ID: 33217362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Who should be prioritized for COVID-19 vaccination in China? A descriptive study.
    Yang J; Zheng W; Shi H; Yan X; Dong K; You Q; Zhong G; Gong H; Chen Z; Jit M; Viboud C; Ajelli M; Yu H
    BMC Med; 2021 Feb; 19(1):45. PubMed ID: 33563270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prioritising older individuals for COVID-19 booster vaccination leads to optimal public health outcomes in a range of socio-economic settings.
    Bouros I; Hill EM; Keeling MJ; Moore S; Thompson RN
    PLoS Comput Biol; 2024 Aug; 20(8):e1012309. PubMed ID: 39116038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Cross-sectional Survey of Public Knowledge and Perspective on Coronavirus Disease, Vaccination, and Related Research in India during the COVID-19 Pandemic.
    Munshi R; Maurya M
    J Assoc Physicians India; 2023 Sep; 71(9):19-27. PubMed ID: 38700297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Outcomes Of A COVID-19 Vaccine: Implementation Over Efficacy.
    Paltiel AD; Schwartz JL; Zheng A; Walensky RP
    Health Aff (Millwood); 2021 Jan; 40(1):42-52. PubMed ID: 33211536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing two-dose vaccine resource allocation to combat a pandemic in the context of limited supply: The case of COVID-19.
    Zhu J; Wang Q; Huang M
    Front Public Health; 2023; 11():1129183. PubMed ID: 37168073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.